Displaying items by tag: therapy Syphilis and cirrhosis: a lethal combination in a XIX century individual identified from the Medical Schools Collection at the University of Coimbra (Portugal) Célia Lopes; Mary Lucas Powell; Ana Luísa Santos PAGE: 1050-1053 | DOI: 10.1590/S0074-02762010000800016 Brazilian flora extracts as source of novel antileishmanial and antifungal compounds André Gustavo Tempone; Patrícia Sartorelli; Denise Teixeira; Frederico O Prado; Ivete ARL Calixto; Harri Lorenzi; Márcia SC Melhem PAGE: 443-449 | DOI: S0074-02762008000500006 Antiviral therapy against chronic hepatitis B in Brazil: high rates of lamivudine resistance mutations and correlation with HBV genotypes Francisco Campello do Amaral Mello; Carlos Augusto Fernandes; Selma de Andrade Gomes PAGE: 317-325 | DOI: 10.1590/S0074-02762012000300005 Hansen's disease: a vanishing disease? Sinésio Talhari; Maria Aparecida de Faria Grossi; Maria Leide WDR de Oliveira; Bernardo Gontijo; Carolina Talhari ; Gerson Oliveira Penna PAGE: 13-16 | DOI: 10.1590/S0074-02762012000900003 Therapy of Tungiasis: a Double-blinded Randomized Controlled Trial with Oral Ivermectin Jörg Heukelbach, Sabine Franck, Hermann Feldmeier PAGE: 873-876 Trypanosoma cruzi-elicited CD8+ T Cell-mediated Myocarditis: Chemokine Receptors and Adhesion Molecules as Potential Therapeutic Targets to Control Chronic Inflammation? Joseli Lannes-Vieira PAGE: 299-304 Detection of Mycobacterium leprae DNA by Polymerase Chain Reaction in the Blood of Individuals, Eight Years after Completion of Anti-leprosy Therapy Adalberto Rezende Santos, Vivian Balassiano, Maria Leide W Oliveira, Marcia Aparecida da Silva Pereira, Patricia Barros Santos, Wim Maurits Degrave, Philip Noel Suffys PAGE: 1129-1133 High and Low Doses of Antimony (Sbv) in American Cutaneous Leishmaniasis. A Five Years Follow-up Study of 15 Patients MP Oliveira-Neto, A Schubach, ML Araujo, C Pirmez PAGE: 207-209 Efficacy of entecavir and tenofovir in chronic hepatitis B under treatment in the public health system in southern Brazil Camila V Pereira, Cristiane Valle Tovo, Thiago K Grossmann, Henrique Mirenda, Bruna B Dal-Pupo, Paulo RL de Almeida, Angelo A de Mattos PAGE: 252-257 | DOI: 10.1590/0074-02760150390 Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre Rosiana Estéfane da Silva, Antonio Toledo Júnior, Maria Camilo Senna, Ana Rabello, Gláucia Cota PAGE: 512-516 | DOI: 10.1590/0074-02760160183 Towards a standard protocol for antimony intralesional infiltration technique for cutaneous leishmaniasis treatment Rosiana Estéfane da Silva, Janaína de Pina Carvalho, Dario Brock Ramalho, Maria Camilo Ribeiro de Senna, Hugo Silva Assis Moreira, Ana Rabello, Erika Cota, Gláucia Cota PAGE: 71-79 | DOI: 10.1590/0074-027601700125 Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial Dario Brock Ramalho, Rosiana Estéfane da Silva, Maria Camilo Ribeiro de Senna, Hugo Silva Assis Moreira, Mariana Junqueira Pedras, Daniel Moreira de Avelar, Lara Saraiva, Ana Rabello, Gláucia Cota DOI: 10.1590/0074-02760180200
Syphilis and cirrhosis: a lethal combination in a XIX century individual identified from the Medical Schools Collection at the University of Coimbra (Portugal) Célia Lopes; Mary Lucas Powell; Ana Luísa Santos PAGE: 1050-1053 | DOI: 10.1590/S0074-02762010000800016
Brazilian flora extracts as source of novel antileishmanial and antifungal compounds André Gustavo Tempone; Patrícia Sartorelli; Denise Teixeira; Frederico O Prado; Ivete ARL Calixto; Harri Lorenzi; Márcia SC Melhem PAGE: 443-449 | DOI: S0074-02762008000500006
Antiviral therapy against chronic hepatitis B in Brazil: high rates of lamivudine resistance mutations and correlation with HBV genotypes Francisco Campello do Amaral Mello; Carlos Augusto Fernandes; Selma de Andrade Gomes PAGE: 317-325 | DOI: 10.1590/S0074-02762012000300005
Hansen's disease: a vanishing disease? Sinésio Talhari; Maria Aparecida de Faria Grossi; Maria Leide WDR de Oliveira; Bernardo Gontijo; Carolina Talhari ; Gerson Oliveira Penna PAGE: 13-16 | DOI: 10.1590/S0074-02762012000900003
Therapy of Tungiasis: a Double-blinded Randomized Controlled Trial with Oral Ivermectin Jörg Heukelbach, Sabine Franck, Hermann Feldmeier PAGE: 873-876
Trypanosoma cruzi-elicited CD8+ T Cell-mediated Myocarditis: Chemokine Receptors and Adhesion Molecules as Potential Therapeutic Targets to Control Chronic Inflammation? Joseli Lannes-Vieira PAGE: 299-304
Detection of Mycobacterium leprae DNA by Polymerase Chain Reaction in the Blood of Individuals, Eight Years after Completion of Anti-leprosy Therapy Adalberto Rezende Santos, Vivian Balassiano, Maria Leide W Oliveira, Marcia Aparecida da Silva Pereira, Patricia Barros Santos, Wim Maurits Degrave, Philip Noel Suffys PAGE: 1129-1133
High and Low Doses of Antimony (Sbv) in American Cutaneous Leishmaniasis. A Five Years Follow-up Study of 15 Patients MP Oliveira-Neto, A Schubach, ML Araujo, C Pirmez PAGE: 207-209
Efficacy of entecavir and tenofovir in chronic hepatitis B under treatment in the public health system in southern Brazil Camila V Pereira, Cristiane Valle Tovo, Thiago K Grossmann, Henrique Mirenda, Bruna B Dal-Pupo, Paulo RL de Almeida, Angelo A de Mattos PAGE: 252-257 | DOI: 10.1590/0074-02760150390
Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre Rosiana Estéfane da Silva, Antonio Toledo Júnior, Maria Camilo Senna, Ana Rabello, Gláucia Cota PAGE: 512-516 | DOI: 10.1590/0074-02760160183
Towards a standard protocol for antimony intralesional infiltration technique for cutaneous leishmaniasis treatment Rosiana Estéfane da Silva, Janaína de Pina Carvalho, Dario Brock Ramalho, Maria Camilo Ribeiro de Senna, Hugo Silva Assis Moreira, Ana Rabello, Erika Cota, Gláucia Cota PAGE: 71-79 | DOI: 10.1590/0074-027601700125
Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial Dario Brock Ramalho, Rosiana Estéfane da Silva, Maria Camilo Ribeiro de Senna, Hugo Silva Assis Moreira, Mariana Junqueira Pedras, Daniel Moreira de Avelar, Lara Saraiva, Ana Rabello, Gláucia Cota DOI: 10.1590/0074-02760180200